Changmao Biochemical Engineering Company Limited (HKG:0954)

Market Cap	172.15M +1.6%
Revenue (ttm)	619.75M -4.8%
Net Income	-74.29M
EPS	-0.14
Shares Out	529.70M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	68,000
Average Volume	50,600
Open	0.3200
Previous Close	0.3200
Day's Range	0.3150 - 0.3250
52-Week Range	0.2550 - 0.3600
Beta	0.42
RSI	47.05
Earnings Date	May 18, 2026

About HKG:0954

Changmao Biochemical Engineering Company Limited, together with its subsidiaries, produces and sells organic acids for food additive, chemical, and pharmaceutical industries in Mainland China, Europe, the Asia Pacific, the United States, and internationally. The company offers maleic anhydride, fumaric acid, maleic acid, L-malic acid, D-malic acid, DL-malic acid, L (+)-tartaric acid, D(-)-tartaric acid, DL-tartaric acid, L-aspartic acid, and aspartame that are used as food additives, medical intermediaries, pharmaceutical adjuvant, active pharm...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1992
• Employees: 509
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0954

Financial Performance

In 2025, HKG:0954's revenue was 556.93 million, a decrease of -4.77% compared to the previous year's 584.79 million. Losses were -66.76 million, -2.17% less than in 2024.

Financial numbers in CNY